Summer Young is an attorney in the firm's Nashville office where she is a member of the Intellectual Property & Technology Service Group.
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
Development of a Series of (1-Benzyl-3(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against y-Thrombin
A Novel Selective PAR4 Antagonist: ML354
Substituted Indoles as Selective Protease Activated Receptor 4 (PAR-4) Antagonists:
Protease Activated Receptor (PAR)1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
Synthesis of Indolederived Protease Activated Receptor 4 Antagonists and Characterization in Human Platelets
Reactivity of the C2'Oxidized Abasic Lesion and Its Relevance to Interactions with Type I Base Excision Repair Enzymes
Summer has served as a technical advisor for the firm's Intellectual Property & Technology Service Group since July 2015. Prior to joining the firm, Summer worked as a law clerk for Vanderbilt Office of the General Counsel (Summer 2015) as well as served as a Pharmacology Research Fellow at Vanderbilt University Medical Center (2013-14). She also served as an intern for Vanderbilt University Center for Technology Transfer & Commercialization (2012-13).
In her off time, Summer enjoys working as an amateur photographer.